Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis

BACKGROUND: Atypical antipsychotic agents (AAP) alleviate the symptoms of severe mental health disorders, such as schizophrenia, by antagonizing dopamine and serotonin receptors. Recently, AAP have also been shown to exhibit immunomodulatory properties in the central nervous system (CNS). OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Laura K, Zareie, Pirooz, Templeton, Nikki, Keyzers, Robert A, Connor, Bronwen, La Flamme, Anne Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453410/
https://www.ncbi.nlm.nih.gov/pubmed/28607752
http://dx.doi.org/10.1177/2055217317698724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453410/
https://www.ncbi.nlm.nih.gov/pubmed/28607752
http://dx.doi.org/10.1177/2055217317698724

Ejemplares similares